Case Reports in Immunology
Volume 2021 (2021), Article ID 2361360, 1 page
https://doi.org/10.1155/2021/2361360

Erratum

Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”

Cesar Daniel Alonso-Bello,¹ María del Carmen Jiménez-Martínez,² María Eugenia Vargas-Camaño,¹ Sagrario Hierro-Orozco,³ Mario Alberto Ynga-Durand,⁴ Laura Berrón-Ruiz,⁵ Julio César Alcántara-Montiel,⁶ Leopoldo Santos-Argumedo,⁶ Diana Andrea Herrera-Sánchez,¹ Fernando Lozano-Patiño,¹ and María Isabel Castrejón-Vázquez¹

¹Immunology and Allergy Department, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico
²Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico
³Dermatology Department, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico
⁴Laboratorio de Inmunidad de Mucosas, Sección de Investigación y Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico
⁵Immunodeficiencies Research Unit, Instituto Nacional de Pediatria, Secretaría de Salud, Mexico City, Mexico
⁶Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico

Correspondence should be addressed to Cesar Daniel Alonso-Bello; cesar_alonso86@hotmail.com

Received 27 October 2020; Accepted 27 October 2020; Published 12 February 2021

Copyright © 2021 Cesar Daniel Alonso-Bello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” [1], authors Mario Alberto Ynga-Durand and Julio César Alcántara-Montiel were affiliated to “Universidad Nacional Autónoma de Mexico, Facultad de Estudios Superiores Zaragoza, Facultad de Medicina, Mexico,” which is incorrect.

The correct affiliation of Mario Alberto Ynga-Durand is “Laboratorio de Inmunidad de Mucosas, Sección de Investigación y Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.” The correct affiliation for Julio César Alcántara-Montiel is “Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico.”

The error was introduced during the production process of the article, and Hindawi apologises for causing this error in the article.

The corrected list of affiliations is shown in the authors’ information above.

References

C. D. Alonso-Bello, M. d. C. Jiménez-Martínez, M. E. Vargas-Camaño et al., “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome,” Case Reports in Immunology, vol. 2019, Article ID 6357256, 5 pages, 2019.